コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 S, a decapping pyrophosphatase, and eIF4E, a translation initiation factor.
2 on has not been previously described for any translation initiation factor.
3 of 4E-BP was dependent on its partner eIF4E translation initiation factor.
4 ependent translation by binding to the eIF4E translation initiation factor.
5 t of a 5' cap and some/all of the associated translation initiation factors.
6 coordinated interaction of a large number of translation initiation factors.
7 tress granule protein G3BP1, and a subset of translation initiation factors.
8 l and cellular mRNAs to compete for limiting translation initiation factors.
9 fold, which was not observed before in other translation initiation factors.
10 that the W73V mutant could not interact with translation initiation factors.
11 oskeletal organization, and the abundance of translation initiation factors.
12 Remarkably, Sui(-) mutations in eukaryotic translation initiation factor 1 (eIF1), eIF1A, and eIF2b
16 phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2alpha) in an AR-dep
17 d PERK specifically phosphorylate eukaryotic translation initiation factor 2 (eIF2alpha) on Ser51 to
18 nse in the liver, including alpha subunit of translation initiation factor 2 (eIF2alpha) phosphorylat
19 ntly increases phosphorylation of eukaryotic translation initiation factor 2 (eIF2alpha) resulting in
21 hosphorylate the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) to activate
22 orylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha), is an impor
23 osphorylates the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha), resulting i
24 osphorylates the alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha), resulting i
27 te (MMS), absence of the full-length form of Translation Initiation Factor 2 (IF2-1) or deficiency in
28 hat, translational control by the eukaryotic translation initiation factor 2 alpha (eIF2alpha) bidire
29 gulated inhibitor kinase (HRI), a eukaryotic translation initiation factor 2 alpha (eIF2alpha) kinase
31 d activation (phosphorylation) of eukaryotic translation initiation factor 2 alpha kinase 3 (EIF2AK3,
32 hereas biallelic mutations in the eukaryotic translation initiation factor 2 alpha kinase 4 gene (EIF
33 result in phosphorylation of the eukaryotic translation initiation factor 2 subunit alpha (EIF2S1 or
34 mmaTE treatment increased phosphorylation of translation initiation factor 2, IkappaBalpha, and JNK,
37 lum stress and phosphorylation of eukaryotic translation initiation factor 2alpha (eIF2alpha) are ass
40 tein levels in the heme-regulated eukaryotic translation initiation factor 2alpha (eIF2alpha) kinase
41 out (PERK-KO) or phosphodeficient eukaryotic translation initiation factor 2alpha (eIF2alpha) mouse e
43 Ppp1r15b, a regulatory subunit of eukaryotic translation initiation factor 2alpha (eIF2alpha) phospha
44 rated stress response mediated by eukaryotic translation initiation factor 2alpha (eIF2alpha) phospho
46 e the regulatory serine 51 of the eukaryotic translation initiation factor 2alpha (eIF2alpha) to inhi
47 se (UPR) associated with phosphorylation the translation initiation factor 2alpha (eIF2alpha), trigge
48 chment activates a canonical PERK-eukaryotic translation initiation factor 2alpha (eIF2alpha)-ATF4-CH
51 edly increased phosphorylation of eukaryotic translation initiation factor 2alpha (p-eIF2alpha), an a
52 -dependent phosphorylation of the eukaryotic translation initiation factor 2alpha and enhanced transl
53 d that the PKR-like, ER-localized eukaryotic translation initiation factor 2alpha kinase branch of th
57 protein kinase-like ER kinase and eukaryotic translation initiation factor 2alpha, and the induction
59 slation initiation factor complex eukaryotic translation initiation factor 2B (eIF2B) and the very-lo
63 nitiation pathway, the 13-subunit eukaryotic translation initiation factor 3 (eIF3) controls access o
67 nslation, a process that involved eukaryotic translation initiation factor 3 subunit b as a P311 bind
69 addition, mTOR co-localised with Eukaryotic translation initiation factor 3 subunit F (eIF3F) at the
71 t the protein translation factor, eukaryotic translation initiation factor 3, subunit a (eIF3a), bind
74 assembly of the mRNA cap protein, eukaryotic translation initiation factor 4 (eIF4)E, with activators
76 dase E (CPE) by inhibition of the eukaryotic translation initiation factor 4 gamma 1 translation init
77 s process facilitates IFN-induced eukaryotic translation initiation factor 4A (eIF4A) activity and bi
79 d4(157-469), a deletion mutant that binds to translation initiation factor 4A (eIF4A), sufficiently i
81 -, beta-, and gamma-subunits) and eukaryotic translation initiation factor 4A (three isoforms), altho
83 In cells depleted of CDK12 or eukaryotic translation initiation factor 4A3 (eIF4A3) from the EJC,
85 rary profiling, we identified the eukaryotic translation initiation factor 4B (eIF4B) as a MELK-inter
86 We confirmed that Asp(563) in eukaryotic translation initiation factor 4B (eIF4B) is a cleavage s
88 e found that the protein level of eukaryotic translation initiation factor 4B (eIF4B), an integral co
89 ORF45 induced phosphorylation of eukaryotic translation initiation factor 4B (eIF4B), increased its
91 tion factor 4E-binding protein 1/ eukaryotic translation initiation factor 4E (4EBP1/eIF4E) cascades.
92 loid leukemia (AML) by regulating eukaryotic translation initiation factor 4E (eIF4E) activation.
93 d to be based on mutations in the eukaryotic translation initiation factor 4E (eIF4E) and its isoform
94 ing serine/threonine kinase (MNK)-eukaryotic translation initiation factor 4E (eIF4E) axis is overexp
98 Here, we show that mice in which eukaryotic translation initiation factor 4E (eIF4E) cannot be phosp
99 ow that a functional reduction of eukaryotic translation initiation factor 4E (eIF4E) in Drosophila s
100 etically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice results
101 translation, and indicate that activation of translation initiation factor 4E (eIF4E) is involved in
105 kappaB alpha (IkappaB-alpha) S32, eukaryotic translation initiation factor 4E (eIF4E) S209, Smad2 S46
108 iation of the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) with eIF4G is a
110 somal protein S6 kinase 1 (S6K1), eukaryotic translation initiation factor 4E (eIF4E), and autophagy,
111 Phosphorylation and activation of eukaryotic translation initiation factor 4E (eIF4E), eIF4E-binding
112 lated or minimally phosphorylated form binds translation initiation factor 4E (eIF4E), preventing bin
113 o Mnk1 lead to phosphorylation of eukaryotic translation initiation factor 4E (eIF4E), which has been
114 imiting factor for translation is eukaryotic translation initiation factor 4E (eIF4E), which is negat
115 e analogues were bound tightly to eukaryotic translation initiation factor 4E (eIF4E), with CCl2-subs
116 o target a specific oncogene, the eukaryotic translation initiation factor 4E (eIF4E), with its inhib
117 ed expression of the translational repressor translation initiation factor 4E (eIF4E)-binding protein
118 d translation of MTFP1, which is mediated by translation initiation factor 4E (eIF4E)-binding protein
119 inhibited phosphorylation of the eukaryotic translation initiation factor 4E (eIF4E)-binding protein
120 t Eap1p, which is a member of the eukaryotic translation initiation factor 4E (eIF4E)-binding protein
121 mice, we investigated the role of eukaryotic translation initiation factor 4E (eIF4E)-eIF4G interacti
122 ignaling are required to activate eukaryotic translation initiation factor 4E (eIF4E)-initiated cap-d
125 eIF4E1b, closely related to the canonical translation initiation factor 4E (eIF4E1a), cap-binding
126 ockade of its downstream effector eukaryotic translation initiation factor 4E activity equally reduce
127 achinery, decreases expression of eukaryotic translation initiation factor 4E and cyclin D1, and indu
128 tion, 4E binding protein 1 (4E-BP1) binds to translation initiation factor 4E and inhibits cap-depend
129 ate the importance of the p38-MNK-eukaryotic translation initiation factor 4E axis in TNF production
130 otein S6, S6 kinase 1 (S6K1), and eukaryotic translation initiation factor 4E binding protein 1 (4E-B
131 TOR)-dependent phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 (4EBP
132 d even under conditions of inhibition of the translation initiation factor 4E function mediated by LY
133 educe the level of phosphorylated eukaryotic translation initiation factor 4E in the tumor tissues.
134 lates the alternative splicing of eukaryotic translation initiation factor 4E nuclear import factor 1
135 ammalian target of rapamycin, and eukaryotic translation initiation factor 4E phosphorylation seen in
137 r 1 (Eif4enif1), which encodes an eukaryotic translation initiation factor 4E transporter (4E-T) prot
138 rget of rapamycin, phosphorylated eukaryotic translation initiation factor 4E, phosphorylated 4E-bind
139 APK-interacting kinase (MNK), and eukaryotic translation initiation factor 4E, which is a critical re
141 p T-shaped structure (kl-TSS) and eukaryotic translation initiation factor 4E-binding Panicum mosaic
143 malian target of rapamycin (mTOR)/eukaryotic translation initiation factor 4E-binding protein (4E-BP)
144 OR) signaling pathway to preserve eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
145 ribosomal protein S6 kinase 1 (S6K1) and the translation initiation factor 4E-binding protein 1 (4E-B
146 serine 345 (S345), Chk 2 S33/35, eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
147 rget of rapamycin (mTOR)-directed eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
148 revealed hyperphosphorylation of eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
149 first, it preferentially targets eukaryotic translation initiation factor 4E-binding protein 1 (4E-B
151 ibosomal protein S6 kinase 1, and eukaryotic translation initiation factor 4E-binding protein 1 durin
152 K/ribosomal protein S6 (RPS6) and eukaryotic translation initiation factor 4E-binding protein 1/ euka
154 l-cycle regulators via the mTORC1/eukaryotic translation initiation factor 4E-binding protein pathway
156 lls through the activation of the eukaryotic translation initiation factor 4E/MAPK-interacting kinase
159 (eIF4G), the scaffold subunit of eukaryotic translation initiation factor 4F (eIF4F), preferentially
160 are required for formation of the eukaryotic translation initiation factor 4F complex (eIF4F) and ini
162 Ser-rich segment (RS1 domain) of eukaryotic translation initiation factor 4G (eIF4G) and the Lys-ric
164 on initiation by interaction with eukaryotic translation initiation factor 4G (eIF4G), we investigate
165 nding partners containing a middle domain of translation initiation factor 4G (MIF4G) are emerging as
166 to bind the poly(A) tail of mRNA, as well as translation initiation factor 4G and eukaryotic release
169 ionine decarboxylase 1 (AMD1) and eukaryotic translation initiation factor 5A (eIF5A), two genes asso
173 ta reveal a transient increase of eukaryotic translation initiation factor 5B (eIF5B), the eukaryotic
176 nduced protein kinase R (PKR) and eukaryotic translation initiation factor alpha (eIF2alpha) phosphor
177 doplasmic reticulum kinase (PERK)-eukaryotic translation initiation factor alpha (eIF2alpha)-CEBP hom
178 omitant with elevated phosphorylation of the translation initiation factor alpha subunit of eukaryoti
179 acids led to significant down-regulation in translation initiation factors, amino acid metabolism, a
180 onucleoprotein (mRNP) aggregates composed of translation initiation factors and mRNAs that appear whe
181 g mRNA-binding proteins, ribosomal proteins, translation initiation factors and translation elongatio
182 election by 5' upstream open reading frames, translation initiation factors, and primary and secondar
183 ing proteins (PABPs) link mRNA 3' termini to translation initiation factors, but they also play key r
184 f eukaryotic initiation factor 2 (eIF2alpha) translation initiation factor by a variety of cellular s
185 udies suggest that the reduced activity of a translation initiation factor called eIF2alpha might be
186 tion between the eIF4E/eIF4G subunits of the translation initiation factor complex eIF4F is a hallmar
187 assays, we show the Saccharomyces cerevisiae translation initiation factor complex eukaryotic transla
189 demonstrates that viruses can increase host translation initiation factor concentration to foster th
193 factors such as ribosomal protein RPS-1 and translation initiation factor EIF-3.J to reduce infectio
194 SG formation is triggered by both eukaryotic translation initiation factor (eIF) 2alpha phosphorylati
195 thways convergently signal to the eukaryotic translation initiation factor (eIF) 4F complex to regula
200 phosphorylation of the alpha subunit of the translation initiation factor eIF2 (eIF2alpha) can promo
201 hosphorylates and in end-effect inhibits the translation initiation factor eIF2 (eukaryotic initiatio
202 ase (OAS), which respectively inactivate the translation initiation factor eIF2 and stimulate RNA cle
205 orylates the alpha subunit of the eukaryotic translation initiation factor eIF2, leading to global do
207 nslational control by phosphorylation of the translation initiation factor eIF2alpha (p-eIF2alpha) ac
208 gene product, phosphorylates the eukaryotic translation initiation factor eIF2alpha and causes trans
209 riggered by increased phosphorylation of the translation initiation factor eIF2alpha and the protein
210 induces Perk-mediated phosphorylation of the translation initiation factor eif2alpha causing selectiv
211 PKR activation leads to phosphorylation of translation initiation factor eIF2alpha inhibition of pr
212 host response to virus infection mediated by translation initiation factor eIF2alpha phosphorylation.
213 study, we found that reduced activity of the translation initiation factor eIF2alpha underlies the hy
215 evels, an extensive dephosphorylation of the translation initiation factor eIF2alpha was observed dur
216 ted by the stress-induced phosphorylation of translation initiation factor eIF2alpha, and this inhibi
217 tivation by PACT leads to phosphorylation of translation initiation factor eIF2alpha, inhibition of p
218 s (MRV) infection induces phosphorylation of translation initiation factor eIF2alpha, which promotes
222 atase activity, dephosphorylating eukaryotic translation initiation factor (eIF2alpha), and derepress
224 , we show that the mRNAs encoding eukaryotic translation initiation factors eIF2B2 and eIF4G2 are pre
225 ng the local protein synthesis of eukaryotic translation initiation factors eIF2B2 and eIF4G2 in the
226 nection between the structure of the central translation initiation factor eIF3 and recognition of th
231 motif (SBM) in two additional proteins: the translation initiation factor eIF3g and the mRNA-export
233 promotes deamidation of glutamine-339 of the translation initiation factor eIF4A, abolishing its heli
234 was associated with increased expression of translation initiation factors eIF4A and eIF4GI, and red
235 wding on structure and function of the human translation initiation factors eIF4A, a two-domain DEAD-
236 e regulates the expression of the eukaryotic translation initiation factor EIF4A1, the tumor suppress
239 d activity of mTORC1 and its downstream mRNA translation initiation factors eIF4B and 4EBP1, as well
241 UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activ
242 of mTOR despite hypoxia involves release of translation initiation factor eIF4E from its repressor p
249 in part, by elevated levels of the activated translation initiation factor eIF4E, overexpression of w
250 d the calcineurin regulator Rcn2, the 4E-BP (translation initiation factor eIF4E-binding protein) tra
256 utcomes and include targeting the eukaryotic translation initiation factor (eIF4E) with its inhibitor
257 tance to asTORi by downregulating eukaryotic translation initiation factor (eIF4E)-binding proteins (
259 e based on mutations in the plant eukaryotic translation initiation factors, eIF4E and eIF4G or their
262 clude the ability to bind a component of the translation initiation factor eIF4F complex and to engag
263 It relies on its ability to compete with the translation initiation factor eIF4F to specifically reco
264 translation by binding the eIF4G subunit of translation initiation factor eIF4F with high affinity.
265 he ability of infected cells to assemble the translation initiation factor eIF4F, promoting viral pro
266 ciated with the 4F subunit of the eukaryotic translation initiation factor (eIF4F) complex in infecte
267 ated in splicing, interacts with the general translation initiation factor eIF4G and promotes transla
268 on factor 4A (eIF4A) activity and binding to translation initiation factor eIF4G to promote mRNA tran
272 mRNA translation mediated by high levels of translation initiation factor eIF4G1 (eukaryotic initiat
273 trate that calpain-mediated degradation of a translation initiation factor, eIF4G1, is a cause of bot
275 carcinoma (PDAC), mutant KRAS stimulates the translation initiation factor eIF5A and upregulates the
276 ch to investigate the role of the eukaryotic translation initiation factor eIF5A in human cervical ca
278 DOHH) catalyzes the activation of eukaryotic translation initiation factor (eIF5A), a protein essenti
280 nt with a decrease in phosphorylation of the translation initiation factor eukaryotic initiation fact
281 Global translation is regulated through the translation initiation factor eukaryotic initiation fact
282 osphorylation-mediated inactivation of a key translation initiation factor, eukaryotic initiation fac
283 uded ribosomal proteins, nucleolar proteins, translation initiation factors, helicases, and hnRNPs.
284 ely to the poorly characterized domain II of translation initiation factor IF2 and prevented the bind
286 element (ARE)-binding protein that recruits translation initiation factors, molecular chaperones, an
287 mes postinfection and contains TIA but lacks translation initiation factors, mRNA binding proteins, a
289 ity, induced oxidative stress, or stimulated translation initiation factor phosphorylation significan
290 l-restricted intracellular antigen 1 (TIA1), translation initiation factors, RNA binding proteins, an
291 protein expression in adipose tissue of the translation initiation factor serine-kinase-6-1, which i
292 SPONSE TO DEHYDRATION14, AUXIN RESISTANT1, a translation initiation factor SUI1 family protein, and t
294 A1 and its highly related isoform eIF5A2 are translation initiation factors that have been implicated
295 which serves as a scaffold to recruit other translation initiation factors that ultimately assemble
296 arrest mediated by the phosphorylation of a translation initiation factor, the alpha subunit of euka
297 tion either by sterically blocking access of translation initiation factors to the 5'-cap or by activ
299 es the eukaryotic initiation factor 2 (eIF2) translation initiation factor upon binding to viral doub
300 s that relies on the interaction of cellular translation initiation factors with the virus genome-enc
301 mechanism that relies on the interaction of translation initiation factors with the virus-encoded VP
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。